Buspirone impurity 3
- CAS NO.:872826-80-7
- Empirical Formula: C8H11N5O
- Molecular Weight: 193.21
- Update Date: 2026-01-13 11:24:12
Properties of Buspirone impurity 3
| Melting point: | 119-120 °C |
| Boiling point: | 437.8±55.0 °C(Predicted) |
| Density | 1.40±0.1 g/cm3(Predicted) |
| pka | 4.87±0.33(Predicted) |
Safety information for Buspirone impurity 3
Computed Descriptors for Buspirone impurity 3
New Products
Dexamethasone Sodium Phosphate p-Anisaldehyde m-Tolualdehyde 2-Bromobenzaldehyde 4-Fluorobenzaldehyde 1-Propyl-4-piperidone 3-Amino-3-(3-fluorophenyl)propanoic acid Raloxifene EP Impurity D N-Nitroso Nortriptyline Nitroso Irbesartan 2-(p-Tolyl)acetaldehyde Sulfonic acid Impurity 2,2-dibromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one 5-Chloro-2-Methoxy-4-Picoline 2-Amino-6-nitrobenzoic Acid (6-Nitroanthranilic acid) Cis-3,5 Diacetoxy-1-cyclopentene 3-Bromo-2-Methoxy-4-Methylpyridine 2-Amino-5-Chloro-3-Nitro-6-picoline 3-Methoxy-5-methylpyrazin-2-amine Pentachlorobenzonitrile Budesonide Nicotinic acid RAPAMYCIN Alpha CyclodextrinRelated products of tetrahydrofuran



![8-(pyrimidin-2-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride](https://img.chemicalbook.in/CAS/20210111/GIF/81461-72-5.gif)


![8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione](https://img.chemicalbook.in/CAS/GIF/21098-11-3.gif)
You may like
-
872826-80-7 2-(4-Nitrosopiperazin-1-yl)pyrimidine 98%View Details
872826-80-7 -
872826-80-7 99%View Details
872826-80-7 -
2-(4-Nitrosopiperazin-1-yl)pyrimidine 99%View Details
872826-80-7 -
12029-98-0 >98%View Details
12029-98-0 -
106-43-4 Parachlorotoluene >99%View Details
106-43-4 -
Pyrrolidin >98%View Details
123-75-1 -
cis-p-Menth-2,8-diene-1-ol 7212-40-0 >98%View Details
7212-40-0 -
Para Chloro toluene (PCT) 106-43-4 >99%View Details
106-43-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
